Waters (NYSE: WAT)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-02 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 2.320 | 2.800 | 0.4800 | ||||
REV | 632.750M | 690.572M | 57.822M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Waters (NYSE: WAT) through any online brokerage.
Other companies in Waters’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Danaher (NYSE:DHR).
The latest price target for Waters (NYSE: WAT) was reported by Barclays on Wednesday, May 18, 2022. The analyst firm set a price target for 375.00 expecting WAT to rise to within 12 months (a possible 9.54% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Waters (NYSE: WAT) is $342.35 last updated July 6, 2022, 7:59 PM UTC.
There are no upcoming dividends for Waters.
Waters’s Q2 earnings are confirmed for Tuesday, August 2, 2022.
There is no upcoming split for Waters.
Waters is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.